ERDF - European Regional Development Fund is one of the European Structural and Investment Funds contributing to smart, sustainable and inclusive growth and aims to strengthen economic, social and territorial cohesion in the EU's regions and cities.
The ERDF was established in 1975 to redress regional disparities within the Community. Under this fund, assistance is provided to less developed regions, focusing mainly on improving public infrastructure and promoting business.
The following studies are carried out within the framework of the ERDF program:
Volatile marker breath analyzer for gastric cancer screenin
The aim of the project is to develop a portable express breath analyzer for gastric cancer screening to determine stomach cancer and pre-cancerous conditions using nanosensor technology that determines breathing organic compounds.
The project is carried out by the European Regional Development Fund (ERDF) 188.8.131.52. Measure "Support for Improvement of Technology Transfer System".
The duration of the project - 01/02/2018 until 27/09/2021
Project identification no. - KC-PI-2017/75
The total funding of the project - EUR 300,000
Project scientific manager - Dr. med. Marcis Leja
More information - HERE
Long term effects of H.pylori eradication on Gastro intestinal tract microbiome and development of screening system for detection of extended-spectrum beta-lactamase coding genes within feces samples.
The aim of this Project is, within the scope of industrial research, to evaluate the long term effects of H.pylori eradication on GIT microbiome, asses its effects on abundance and prevalence of extended-spectrum b-lactamases coding genes and develop cost effective ESBL screening test prototype. The results acquired through the implementation of this Project shall provide us with enhanced understanding on long term effects of antimicrobial agents on GIT microbiome and development of antibiotic resistance. They shall also contribute to development of National eradication treatment strategy.
The project is non-economic and is in line with the Biotechnology industry. It will be implemented in the "Latvian Biomedical Research and Study Center" and "University of Latvia".
The project is carried out under the European Regional Development Fund (ERDF), Measure 184.108.40.206 “Industry-Driven Research”.
The duration of the study - 01/03/2017 - 29/02/2020
Project Nr. - 220.127.116.11/16/A/272
Project costs - 648 648, 00 EUR
Principle Investigator - Dr. biol. D. Fridmanis
Collaboration - Latvian Biomedical Research and Study Center
More information - HERE